Recombinant YhiD (gene identifier yhiD, UniProt ID P0AFV2) is an uncharacterized protein in Escherichia coli K-12, also annotated as yhhE, b3508, or JW5670. While its precise biological function remains unclear, structural and proteomic studies suggest potential roles in magnesium transport or cellular metabolism . Commercial recombinant YhiD is produced as a full-length protein (1–215 amino acids) fused with an N-terminal His-tag, enabling affinity purification and biochemical analysis .
YhiD lacks annotated functional domains but exhibits sequence features consistent with membrane-associated or transport-related proteins. Its full-length sequence includes:
N-terminal His-tag for purification.
215 amino acids, with a predicted molecular weight of ~25 kDa (estimated from sequence composition).
Cysteine-rich regions (e.g., C-terminal motifs), though their functional significance remains unexplored .
YhiD has been implicated in:
Magnesium Transport: Annotated as a putative magnesium transporter based on sequence homology, though experimental validation is lacking .
Protein Synthesis or RNA Metabolism: Proteomic studies link YhiD to networks involving ribosomal proteins, RNA helicases, and degradosome components, suggesting a role in translation regulation or mRNA stability .
Recent metabolic burden studies highlight strain-specific differences in recombinant protein production. For example:
DH5α vs. M15 strains: YhiD expression may vary due to differences in transcriptional machinery, lipid biosynthesis, or nutrient uptake pathways .
Structural Studies: Recombinant YhiD enables X-ray crystallography or NMR analysis to elucidate its fold and binding interactions.
Functional Screening: Knockout mutants (ΔyhiD) could reveal phenotypic effects on magnesium homeostasis or growth under stress conditions.
Functional Elucidation: No direct evidence links YhiD to magnesium transport or translation regulation.
Structural Data: Limited availability of crystal structures or interaction partners hinders mechanistic insights.
Redundancy: Potential functional overlap with paralogs (e.g., yhhE) complicates phenotypic analysis.
KEGG: ecj:JW5670
STRING: 316385.ECDH10B_3684
The selection of an appropriate expression system is critical for successful production of uncharacterized proteins like YhiD. Research indicates that medium to low copy number vectors often yield better protein production than high copy plasmids . For example, vectors containing the p15A origin of replication demonstrated higher expression levels compared to high copy vectors in similar experimental setups .
When expressing membrane proteins or uncharacterized proteins, the combination of promoter strength and vector copy number significantly impacts expression efficiency. Strong promoters (like P trc) in combination with low copy vectors have shown up to threefold higher expression than P T7 and 5.5-fold higher than Plac promoters in comparable systems . For YhiD expression, a system using the pSF-p15A backbone with a trc promoter would likely provide optimal conditions, as similar configurations yielded up to 53.09 mg/L of recombinant protein in comparable studies .
Confirming expression of uncharacterized proteins requires multiple verification methods:
SDS-PAGE analysis: Run soluble and insoluble fractions to determine protein presence and distribution
Western blotting: Using antibodies against fusion tags (His, GST, or FLAG) if the native protein lacks reliable antibodies
Mass spectrometry: For definitive identification of the expressed protein
Functional assays: Develop based on predicted protein characteristics or homology models
Quantitative analysis should include densitometric measurements of protein bands, similar to approaches used for other recombinant proteins in E. coli . When working with uncharacterized proteins like those in the UPF0016 family, confirmation of expression often relies on fusion tags or reporter systems until specific antibodies become available .
Expressing uncharacterized proteins presents several challenges that require methodological solutions:
Inclusion body formation: Studies show that even with optimized expression systems, a significant percentage of recombinant protein can form insoluble aggregates . For instance, expression under P BAD promoter control showed lower insoluble fraction compared to other promoters in similar experimental setups .
Metabolic burden: The metabolic load imposed by protein overexpression can significantly impact cell growth and protein yields. Research has demonstrated that the combination of high copy number plasmids with strong promoters causes metabolic mismatch and decreased productivity .
Protein toxicity: Membrane or regulatory proteins may disrupt cellular processes when overexpressed.
Improper folding: Without known structural information, achieving proper folding can be particularly challenging.
A strategic approach involves testing multiple expression conditions, including various promoters, induction temperatures (20°C, 30°C, 37°C), and carbon sources (glucose vs. glycerol) .
Characterizing uncharacterized proteins requires a systematic experimental design approach:
Sequential hypothesis testing: Start with bioinformatic predictions of protein function based on sequence motifs and structural homology. For instance, if YhiD contains motifs similar to the UPF0016 family (e.g., Glu-x-Gly-Asp-(Arg/Lys)-(Ser/Thr)), it may suggest membrane transport functionality .
Controlled variable manipulation: Following true experimental design principles, systematically manipulate independent variables while controlling for extraneous factors . For YhiD characterization, this might include:
| Independent Variable | Levels to Test | Dependent Variable | Control Factors |
|---|---|---|---|
| Growth conditions | Aerobic, Anaerobic, Microaerobic | YhiD expression levels | Temperature, media composition |
| Stress conditions | pH, osmotic, oxidative stress | Cellular phenotype | Growth phase, strain background |
| Metal ions | Ca²⁺, Mg²⁺, Mn²⁺, Zn²⁺ | Protein activity | pH, temperature, buffer composition |
| Gene knockouts | Related pathway genes | Metabolic flux | Growth conditions, carbon source |
Randomization: Ensure random distribution of experimental units to treatment groups to prevent selection bias and control for confounding variables .
Replication: Include sufficient biological and technical replicates, with statistical power analysis to determine appropriate sample sizes .
An approach using complementary methods (biochemical assays, phenotypic analyses, and omics techniques) provides the most robust characterization strategy for uncharacterized proteins like YhiD.
Addressing solubility challenges requires a multi-faceted approach:
Expression optimization: Research has shown that even with optimal expression systems, recombinant proteins can form significant insoluble fractions. For example, studies with YFP expression vectors demonstrated that cultures containing pSF-p15A-trc-YFP and pSF-p15A-tac-YFP showed similar percentages of soluble and insoluble protein despite high expression levels .
Fusion tags selection: Various solubility-enhancing tags can be empirically tested:
| Fusion Tag | Molecular Weight | Solubility Enhancement | Purification Method |
|---|---|---|---|
| MBP | 42 kDa | High | Amylose resin |
| SUMO | 11 kDa | Moderate to high | Ni-NTA (with His) |
| Thioredoxin | 12 kDa | Moderate | Various |
| GST | 26 kDa | Moderate | Glutathione |
| NusA | 55 kDa | High | Various |
Chaperone co-expression: Co-expressing molecular chaperones (GroEL/ES, DnaK/J, trigger factor) can significantly improve folding of difficult proteins.
Inclusion body recovery: If YhiD consistently forms inclusion bodies, solubilization and refolding protocols can be developed using chaotropic agents (urea, guanidine-HCl) followed by controlled dialysis.
Research has demonstrated that the percentage of soluble versus insoluble protein varies significantly based on the expression system, with P BAD promoter systems showing improved solubility profiles compared to stronger promoters in comparable experimental setups .
Investigating protein-protein interactions for uncharacterized proteins requires strategic experimental approaches:
Affinity purification coupled with mass spectrometry (AP-MS): Express tagged YhiD (His, FLAG, or Strep tag) to capture protein complexes under near-physiological conditions.
Bacterial two-hybrid screening: Systematic testing for binary interactions with E. coli proteome subsets. This approach uses the following experimental design:
| Component | System 1 | System 2 | System 3 |
|---|---|---|---|
| Bait | YhiD-T18 | YhiD-λcI | YhiD-LexA |
| Prey | T25-library | RNA polymerase-library | B42-library |
| Reporter | β-galactosidase | Reporter gene | LEU2 or lacZ |
| Selection | Blue/white | Growth | Growth or color |
Proximity-dependent biotin labeling (BioID or APEX): For capturing transient or weak interactions within the native cellular environment.
Co-immunoprecipitation: If antibodies are available or using epitope-tagged versions of YhiD.
Genetic approaches: Synthetic lethality screening, suppressor analysis, and genetic interaction mapping can reveal functional relationships.
For membrane proteins or proteins of unknown function, combining multiple complementary approaches yields the most reliable interaction data. When analyzing results, statistical methods for controlling false discovery rates are essential for distinguishing true interactions from background contaminants.
The choice of promoter significantly impacts recombinant protein expression success. Research has demonstrated distinct expression profiles with different promoter systems:
Trc promoter: Achieved the highest expression levels (up to 53.09 mg/L) when combined with low-copy p15A origin vectors . This represents a threefold higher expression than P T7 and 5.5-fold higher than Plac in comparable systems .
BAD promoter: Showed improved performance with high copy plasmids, likely due to its weaker strength compared to lac-derived promoters . This promoter also demonstrated reduced insoluble protein fraction formation compared to stronger promoters .
T7 promoter: Despite being widely used for recombinant protein expression, showed only moderate expression levels for proteins similar to YhiD when compared to trc promoter systems .
For uncharacterized proteins like YhiD, which may have unknown functional characteristics or potential toxicity, tightly regulated promoter systems are advisable. The following table summarizes promoter characteristics based on experimental data:
| Promoter | Regulation | Relative Strength | Leakiness | Induction Method | Suitable for Toxic Proteins |
|---|---|---|---|---|---|
| Ptrc | Moderate | High | Moderate | IPTG | No |
| PBAD | Tight | Medium | Low | L-arabinose | Yes |
| PT7 | Tight | Very high | Moderate | IPTG | No |
| Plac | Moderate | Low-Medium | High | IPTG | Yes |
For YhiD expression, starting with the PBAD system would be recommended if toxicity is a concern, while the trc promoter would be optimal for maximum expression if the protein does not negatively impact cell viability .
The choice of carbon source significantly impacts recombinant protein expression efficiency. Experimental evidence shows:
Glycerol versus glucose: Studies demonstrated that E. coli grown with glycerol as carbon source achieved higher recombinant protein expression compared to glucose-supplemented cultures, with the maximum expression observed in wild-type E. coli growing with glycerol transformed with the plasmid pSF-p15A-trc-YFP .
Metabolic impact: Glucose can cause carbon catabolite repression, affecting the expression from certain promoters. Additionally, acetate accumulation during glucose metabolism can negatively impact protein expression and cell growth .
Strain-specific effects: The carbon source impact varies between wild-type and metabolically engineered strains. For instance, the Δ ackA mutant (deficient in acetate kinase) showed differential expression patterns compared to wild-type when grown on different carbon sources .
For YhiD expression, initial trials should compare glycerol-supplemented media with traditional glucose-based formulations. Based on comparable studies, glycerol supplementation could potentially increase expression yields by 15-40% depending on the specific expression system employed .
Comprehensive characterization of uncharacterized proteins requires multiple complementary analytical approaches:
Structural analysis:
X-ray crystallography for high-resolution structural determination
Cryo-electron microscopy for membrane proteins or large complexes
NMR spectroscopy for dynamic structural information
Small-angle X-ray scattering (SAXS) for solution-state structural envelopes
Functional assessment:
Phenotypic analysis of knockout/overexpression strains
Metabolomic profiling to identify altered metabolic pathways
Transcriptomic analysis to identify gene expression changes
Membrane transport assays if predicted to be a transporter
Biochemical characterization:
Enzymatic activity assays based on predicted function
Binding assays for potential substrates or interactors
Thermal shift assays for stability assessment and ligand binding
Circular dichroism for secondary structure assessment
For proteins belonging to uncharacterized families, such as UPF0016, sequence motif analysis can provide initial functional hints, such as the conserved Glu-x-Gly-Asp-(Arg/Lys)-(Ser/Thr) motif that suggests potential membrane transport or ion channel activity .
Distinguishing true results from artifacts when working with uncharacterized proteins requires rigorous experimental design and controls:
True experimental design implementation: Follow the core principles of experimental design including randomization, replication, and controlled variable manipulation . This requires:
Multiple detection methods: Validate findings using orthogonal techniques:
| Primary Method | Confirmatory Method | Control for Artifact |
|---|---|---|
| Western blot | Mass spectrometry | Non-specific antibody binding |
| Phenotypic assay | Complementation test | Strain-specific effects |
| Overexpression | CRISPR interference | Non-physiological levels |
| Fluorescent tagging | Subcellular fractionation | Tag interference |
System-specific controls: For uncharacterized proteins, include:
Expression of known proteins under identical conditions
Parallel expression of tagged and untagged versions
Tests with functionally validated homologs from related organisms
Empty vector controls for phenotypic assessments
Data verification: Apply statistical methods to distinguish signal from noise:
Computational prediction of function for uncharacterized proteins involves several complementary approaches:
Sequence-based predictions:
Hidden Markov Model (HMM) profiling against known protein domains
Identification of conserved sequence motifs
Multiple sequence alignment with functionally characterized homologs
Phylogenetic analysis to identify orthologs with known functions
Structure-based predictions:
Homology modeling using structurally characterized templates
Ab initio structure prediction using AlphaFold2 or RoseTTAFold
Molecular docking to predict potential binding partners
Active site prediction and comparison with known enzyme families
Systems biology approaches:
Gene neighborhood analysis across different bacterial species
Gene co-expression network analysis
Protein-protein interaction prediction
Phenotype-based function prediction using genome-wide datasets
For proteins in uncharacterized families like UPF0016, which contains conserved motifs such as Glu-x-Gly-Asp-(Arg/Lys)-(Ser/Thr), these computational predictions can provide initial hypotheses about potential membrane transport functions, subcellular localization, or involvement in specific cellular processes .
A systematic knockout/complementation approach requires careful experimental design following these steps:
Generation of clean knockout strains:
Gene deletion using λ-Red recombineering system
CRISPR-Cas9 based genome editing
Verification of knockout by PCR, sequencing, and expression analysis
Phenotypic characterization:
| Condition to Test | Measurements | Technical Considerations |
|---|---|---|
| Standard growth | Growth rate, cell morphology | Multiple media types |
| Stress conditions | Survival rates | pH, temperature, osmotic stress |
| Metabolic profiling | Metabolite concentrations | Various carbon sources |
| Membrane integrity | Permeability assays | Multiple indicators |
Complementation strategy:
Wild-type gene under native promoter
Wild-type gene under inducible promoter
Site-directed mutants targeting conserved residues
Homologs from related organisms
Controls and validation:
Empty vector controls
Complementation with unrelated genes
Restoration of original locus (genetic reversion)
Dosage dependency assessment
This approach should follow true experimental design principles by:
Randomizing experimental units to prevent bias
Including sufficient biological and technical replicates
Controlling for extraneous variables
For uncharacterized proteins like YhiD, complementation with homologs from well-studied organisms can provide additional functional insights while mutational analysis of conserved motifs can help identify critical functional residues.